Article
Inhibitory effects of cytoskeleton disrupting drugs and GDP-locked Rab mutants on bradykinin B₂ receptor cycling.
Pharmacological research - 1 May 2013
Charest-Morin Xavier, Fortin Sébastien, Lodge Robert, Roy Caroline, Gera Lajos, Gaudreault René C, Marceau François
Abstract excerpt
The bradykinin (BK) B₂ receptor (B₂R) is G protein coupled and phosphorylated upon agonist stimulation; its endocytosis and recycling are documented. We assessed the effect of drugs that affect the cytoskeleton on B2R cycling. These drugs were targeted to tubulin (paclitaxel, or the novel combretastatin A-4 mimetic 3,4,5-trimethoxyphenyl-4-(2-oxoimidazolidin-1-yl)benzenesulfonate [IMZ-602]) and actin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
